Quick Answer
Entera Bio Ltd. reported Stockholders Equity of $13.10 million for fiscal year 2025.
Entera Bio Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $13.10M | +62.1% |
| 2024 | $8.08M | -22.2% |
| 2023 | $10.39M | -11.6% |
| 2022 | $11.75M | -47.9% |
| 2021 | $22.57M | +200.5% |
| 2020 | $7.51M | -45.5% |
| 2019 | $13.77M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.23M | +136.1% | -11.7% |
| June 30, 2025 | $17.26M | +102.3% | -11.0% |
| March 31, 2025 | $19.38M | +118.7% | +139.8% |
| December 31, 2024 | $8.08M | -22.2% | +25.2% |
| September 30, 2024 | $6.45M | +3.5% | -24.4% |
| June 30, 2024 | $8.53M | +3.6% | -3.7% |
| March 31, 2024 | $8.86M | -12.1% | -14.7% |
| December 31, 2023 | $10.39M | -11.6% | +66.5% |
- Entera Bio Ltd. showed an increase of +62.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Entera Bio Ltd.’s stockholders equity has declined by 4.9% (from $13.77 million to $13.10 million).
- The most recent figure is from Entera Bio Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: